USANA Health Sciences Earnings Report and Insider Trading Update

USANA HEALTH SCIENCES ($USNA) is on track to announce its quarterly earnings data on Tuesday, April 22nd, following the market’s close, according to Finnhub. Analysts expect the company to report revenue of $247,904,880 and earnings of $0.72 per share.

Investors can monitor Quiver Quantitative’s $USNA Stock page for insights on insider trading, hedge fund activities, and other relevant information.

Recent Insider Trading Activity in USANA Health Sciences

In the past six months, USANA HEALTH SCIENCES insiders have executed a total of 8 trades involving $USNA Stock. Notably, there have been no purchases; all trades were sales.

Below is a summary of the recent trading activity involving $USNA Stock by insiders:

• JOSHUA FOUKAS (CHIEF LEGAL OFFICER) sold 5,732 shares for approximately $186,513
• BRENT NEIDIG (CHIEF COMMERCIAL OFFICER) sold 4,743 shares for around $153,387
• JIM BROWN (CEO & PRESIDENT) sold 5,000 shares for about $147,350
• DAVID MULHAM MULHAM (CHIEF SALES OFFICER) sold 3,234 shares for an estimated $106,669
• GILBERT A FULLER made no purchases and conducted 2 sales, offloading 1,349 shares for approximately $46,647
• PEGGIE PELOSI sold 780 shares for an estimated $21,918
• JOHN TURMAN FLEMING sold 500 shares for around $16,647

To stay updated with insider transactions, visit Quiver Quantitative’s insider trading dashboard.

Hedge Fund Activity Surrounding USANA Health Sciences

Recently, 70 institutional investors have increased their positions in USANA HEALTH SCIENCES Stock, while 67 have reduced their stake in the last quarter.

Highlighted below are some of the most significant recent changes:

• UBS GROUP AG divested 99,383 shares (-53.8%) in Q4 2024, totaling approximately $3,566,855
• ROYAL BANK OF CANADA added 97,730 shares (+2623.6%) in Q4 2024, for an estimated $3,507,529
• RENAISSANCE TECHNOLOGIES LLC decreased its holdings by 58,400 shares (-5.1%) in Q4 2024, valued at approximately $2,095,976
• VANGUARD GROUP INC cut 55,795 shares (-3.5%) from its portfolio in Q4 2024, amounting to about $2,002,482
• DIMENSIONAL FUND ADVISORS LP increased its shares by 55,059 (+7.7%) in Q4 2024, valued at approximately $1,976,067
• PACER ADVISORS, INC. added 47,745 shares (+8.8%) in Q4 2024, for an estimated $1,713,568
• GOLDMAN SACHS GROUP INC raised its position by 42,884 shares (+74.4%) in Q4 2024, worth about $1,539,106

For a look into the portfolios of hedge funds, visit Quiver Quantitative’s institutional holdings dashboard.

This article does not constitute financial advice. Please refer to Quiver Quantitative’s disclaimers for additional information. Inaccuracies may arise due to ticker-mapping errors and other anomalies.

This article was originally published on Quiver News. To read the full story, visit the source.

The views and opinions expressed herein are those of the author and do not necessarily reflect the views of Nasdaq, Inc.